Comprehensive treatment for the peritoneal metastasis from gastric cancer

• 作者: Akiyosi Mizumoto Bjorn Bruher Emel Canbay Haruaki Ishibashi Kazuyoshi Takeshita Kousuke Noguchi Masamitu Hirano Masumi Ichinose Nobuyuki Takao Oliver Glehen Paul H Sugarbaker Takuya Saitou Yan Li Yang Liu Yoshio Endou Yutaka Yonemura
• 来源期刊: 世界外科手术杂志
• 学科: 医学
• 关键词: Gastric cancer Hyperthermic INTRAOPERATIVE INTRAPERITONEAL chemotherapy PERITONEAL METASTASIS PERITONECTOMY
• 年，卷（期）: sjwksszz,（2）
• 页码范围: 187-197
• 页数: 11页
• 分类号: R

摘要

Recently,a novel comprehensive treatment consisting of cytoreductive surgery(CRS)and perioperative chemotherapy(POC)was developed for the treatment of peritoneal metastasis(PM)with a curative intent.In the treatment,the macroscopic disease is completely removed by the peritonectomy techniques in combination with POC.This article reviews the results of the comprehensive treatment for PM from gastric cancer,and verifies the effects of CRS and POC,including neoadjuvant chemotherapy(NAC)and hyperthermic intraoperative intraperitoneal chemotherapy(HIPEC).Completeness of cytoreduction,peritoneal carcinomatosis index(PCI)less than the threshold levels after NAC,absence of ascites,cytologic status,pathologic response after NAC are the independent prognostic factors.Among these prognostic factors,PCI threshold level is the most valuable independent prognostic factor.After staging laparoscopy,patients with PM from gastric cancer are recommended to treat with NAC before CRS.After NAC,indication for CRS is determined by laparoscopy.The indications of the comprehensive treatment are patients with PCI less than the threshold levels,negative cytology,and responders after NAC.Patients satisfy these factors are the candidates for the CRS and HIPEC.